SCHEMBL6227199

SCHEMBL6227199

CCn1ncc(C#N)c1N.c1cc2cc-2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
PKM P14618 1/20 0.46
FNTA P49354 1/20 0.43
FNTB P49356 1/20 0.43
CYP11B2 P19099 1/20 0.41
KDM4E B2RXH2 7/20 0.41
NPSR1 Q6W5P4 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
RXFP1 Q9HBX9 2/20 0.41
CSNK2A1 P68400 1/20 0.40
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 5/20 0.39
MAPK1 P28482 2/20 0.38
LMNA P02545 1/20 0.38
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2193196 0.87 PKM (0.55) KMT2APKMFNTAFNTBCYP11B2
SCHEMBL2077595 0.74 PKM (0.53) KMT2APKMFNTAFNTBCYP11B2
SCHEMBL4760141 0.72 PKM (0.50) KMT2APKMFNTAFNTBKDM4E
SCHEMBL2073708 0.71 PKM (0.49) KMT2APKMFNTAFNTBKDM4E
SCHEMBL164239 0.71 TSHR (0.59) KMT2APKMFNTAFNTBKDM4E
SCHEMBL8234335 0.71 PKM (0.55) KMT2APKMFNTAFNTBCYP11B2
SCHEMBL6228129 0.71 KDM4E (0.35) KMT2AKDM4ENPSR1NPC1RAB9A
SCHEMBL2078439 0.70 PKM (0.51) KMT2APKMFNTAFNTBKDM4E
SCHEMBL1740693 0.70 PKM (0.48) KMT2APKMFNTAFNTBKDM4E
SCHEMBL11899586 0.70 PKM (0.48) KMT2APKMFNTAFNTBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499614-A4 ADENOSINE A3 RECEPTOR MODULATORS KING PHARMACEUTICALS RES & DEV (US) 2005-08-24 EP disclosed
EP-1499614-A1 ADENOSINE A3 RECEPTOR MODULATORS King Pharmaceuticals Research and Development Inc. (US) 2005-01-26 EP disclosed
WO-2003095457-A1 ADENOSINE A3 RECEPTOR MODULATORS KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) 2003-11-20 WO disclosed